NFKB1 and Sepsis: Despite our previous in vivo study showing that BBR can inhibit the sepsis-induced TLR4/NF-κB signaling pathway (Chen H. et al., 2021), the mechanism of BBR’s treatment of SCM is very complex and requires further research, particularly regarding the role of BBR in SCM.